Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Equity Stake

19 Jun 2007 11:44

Quadrise Fuels International PLC19 June 2007 19th June 2007 AIM: QFI Quadrise Fuels International plc ("Quadrise" or "the Company") Quadrise Canada Corporation acquires equity stake in Clean Energy Systems Inc Quadrise Canada Corporation ("QCC"), and Paxton Corporation ("Paxton") havejointly entered into an agreement with Clean Energy Systems Inc ("CES") ofSacramento, USA. The agreement is for an aggregate equity position in CES, afterexercise of all rights and warrants of approximately 18% on a fully dilutedbasis. Quadrise Fuels International ("QFI"), the AIM listed specialistmanufacturer of MSAR(R) emulsion fuel has a 20% equity stake in QCC and an 8%equity stake in Paxton. In exchange for this position, Paxton and QCC will provide funds for developmentof the CES power generation system. The development programme will focus ondesigning and manufacturing a 12" gas generator capable of producing 65MW ofelectrical power. CES have numerous patents and filed additional patent applications that form thebasis for the first Zero Emission Power Plant (ZEPPTM) in the USA. The CESsystem envisages oxy-firing of a wide range of fuels including the Quadriseproduct, MSAR(R). Oxy-firing permits capture of the combustion product, carbondioxide (the greenhouse gas) in a concentrated form. The high concentrationcarbon dioxide produced in this manner is of a quality suitable for injectioninto hydrocarbon reservoirs to enhance oil recovery and is of considerable valueto the petroleum industry Bill Howe, Chief Executive of Quadrise Fuels International, commented: "Carbondioxide is in short supply in North America. The CES technology offers theopportunity of co-production of saleable power and by-product carbon dioxidefrom in situ oil, together with enhanced oil recovery and simultaneouselimination of greenhouse gas emissions. For QFI, the development of a powergeneration system that was tested using MSAR(R), and has so many 'value add'features is a fundamental progression for the company." Running concurrently with the generator development programme, Paxton is workingwith CES to develop a commercial scale 65MW zero emission MSAR(R) fuelled powerplant in California. For further information, please contact: Quadrise Fuels International plcBill Howe, CEOT: +44 (0)20 7550 4930 Smith & Williamson Corporate Finance LimitedAzhic Basirov / Siobhan Sergeant+44 (0)20 7131 4000 Parkgreen CommunicationsSimon Robinson / Clare Irvine+44 (0)20 7851 7480 Notes to editors: Quadrise Fuels International plc ("Quadrise") produces an emulsion fuel as a lowcost substitute for conventional heavy fuel oil ("HFO") for use in powergeneration plants and large steam raising or energy consuming industries. In manufacturing its fuels, Quadrise uses the least valuable elements of the oilbarrel, thus providing a very cost effective product whilst simultaneouslyfacilitating a means to market for the least desirable heavy crudes and refineryderived residues. The emulsion fuel product, termed MSAR(R) (Multiphase Superfine AtomisedResidue), has superior combustion characteristics to conventional HFO and coal,and has comparable or superior environmental performance in respect ofgreenhouse emissions. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
29th Nov 20197:00 amRNSAGM Update
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.